Koen Vandyck

2.1k citations

24 papers · 1.3k indexed · h-index 17

Hepatology top 5%
- Hepatitis C virus research 7
Endocrinology, Diabetes and Metabolism top 5%
Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 3
Epidemiology top 10%
- Hepatitis B Virus Studies 5
Organic Chemistry top 10%
- Synthetic Organic Chemistry Methods 3
- Asymmetric Synthesis and Catalysis 3
Inorganic Chemistry
- Asymmetric Hydrogenation and Catalysis 5
Spectroscopy
- Molecular spectroscopy and chirality 4
Atomic and Molecular Physics, and Optics
- Spectroscopy and Quantum Chemical Studies 3

Co-authors: Johan Van der Eycken Jérôme Deval Michael Tanen Gary Herman C. Melinda Stevens Bingming Yi Arthur Bergman Wesley Tanaka
Cited by: Hepatology Endocrinology, Diabetes and Metabolism Infectious Diseases
Journals: Antimicrobial Agents and Chemotherapy (3 papers)Antiviral Research (3 papers)Journal of Medicinal Chemistry (3 papers)
Partner nations: Belgium United States Sweden

In The Last Decade

Koen Vandyck

24 papers receiving 1.2k citations

Peers

Countries citing papers authored by Koen Vandyck

Since Specialization

Citations

This map shows the geographic impact of Koen Vandyck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koen Vandyck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koen Vandyck more than expected).

Fields of papers citing papers by Koen Vandyck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koen Vandyck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koen Vandyck. The network helps show where Koen Vandyck may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Koen Vandyck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Koen Vandyck Line = papers co-authored together Koen Vandyck links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development Antiviral Research ·Cheng Liu,Sandro Boland,Michael D. Scholle,Dorothée Bardiot,Arnaud Marchand,Patrick Chaltin,Lawrence M. Blatt,Leonid Beigelman,Julian Symons,Pierre Raboisson,Zachary A. Gurard‐Levin,Koen Vandyck,Jérôme Deval	2021	39
2	Development of a cellular high-content, immunofluorescent HBV core assay to identify novel capsid assembly modulators that induce the formation of aberrant HBV core structures Journal of Virological Methods ·Katharina Siedler,Karen Vergauwen,Steffen Jaensch,Emmanuel Gustin,Christoph Rüttimann,Peter Vermeulen,Aaron Lin,Koen Vandyck,Frederik Pauwels,Jan Martin Berke	2021	6
3	Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection Current Opinion in Virology ·Koen Vandyck,Jérôme Deval	2021	98
4	Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry Antiviral Research ·Zachary A. Gurard‐Levin,Liu C,Andreas Jekle,Casado Repiso M,Suping Ren,Koen Vandyck,Dirk Jochmans,Pieter Leyssen,Johan Neyts,Lawrence M. Blatt,Leonid Beigelman,Julian Symons,Pierre Raboisson,Michael D. Scholle,Jérôme Deval	2020	26
5	Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH) PLoS ONE ·Xuan G. Luong,Sarah Stevens,Andreas Jekle,Tse‐I Lin,Kusum Gupta,Dinah Misner,Sushmita Chanda,Joshua Corriveau,Caroline Williams,Antitsa Stoycheva,Lawrence M. Blatt,S. Ramsaran,Julian Symons,Pierre Raboisson,David C. McGowan,Koen Vandyck,Takayoshi Sumi	2020	31
6	Antiviral Properties and Mechanism of Action Studies of the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379 Antimicrobial Agents and Chemotherapy ·Jan Martin Berke,Pascale Dehertogh,Karen Vergauwen,Wendy Mostmans,Koen Vandyck,Pierre Raboisson,Frederik Pauwels	2020	55
7	Abstract 1758: Discovery of novel potent and selective inhibitors of PRMT5 with anti-tumor activity in hepatocellular carcinoma and lung pre-clinical models Cancer Research ·François Gonzalvez,Koen Vandyck,Yannick Debing,Kusum Gupta,Dinah Misner,Qingling Zhang,Jordi Galceran,Antitsa Stoycheva,Cailin Li,Julian Symons,Leonid Beigelman,Pierre Raboisson,Huang Tong	2020	1
8	Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle Antimicrobial Agents and Chemotherapy ·Thomas Lahlali,Jan Martin Berke,Karen Vergauwen,Cosío Villa,Koen Vandyck,Frederik Pauwels,Fabien Zoulim,David Durantel	2018	76
9	Synthesis and Evaluation of N-Phenyl-3-sulfamoyl-benzamide Derivatives as Capsid Assembly Modulators Inhibiting Hepatitis B Virus (HBV) Journal of Medicinal Chemistry ·Koen Vandyck,Geert Rombouts,Bart Stoops,Abdellah Tahri,Ann Vos,R.G. De Almeida,Yiming Wu,琦轩周,Jay Wierer,Z.C. Warner,Karen Vergauwen,Pascale Dehertogh,Jan Martin Berke,Pierre Raboisson	2018	42
10	Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library Antiviral Research ·滋成長谷川,Peggy Geluykens,خـاسف جمال الدين,清策森田,Olivia Goethals,Bilinç Doğruöz Karatekin,T. Prazuck,Stefaan Last,David C. McGowan,Thomas Koellner,Benoît De Boeck,Bart Stoops,Benoit Devogelaere,Frederik Pauwels,Koen Vandyck,Jan Martin Berke,Pierre Raboisson,Kenneth Simmen,Péter Hajnal,Marnix Van Loock	2017	15
11	Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human Hepatocytes Infected with Hepatitis B Virus Antimicrobial Agents and Chemotherapy ·Jan Martin Berke,Pascale Dehertogh,Karen Vergauwen,Ellen Van Damme,Wendy Mostmans,Koen Vandyck,Frederik Pauwels	2017	116
12	Structure-Based Design of a Benzodiazepine Scaffold Yields a Potent Allosteric Inhibitor of Hepatitis C NS5B RNA Polymerase Journal of Medicinal Chemistry ·Koen Vandyck,Maxwell D. Cummings,Origène Nyanguile,Carlo Boutton,Sandrine Vendeville,David C. McGowan,Benoit Devogelaere,Katie Amssoms,Stefaan Last,唐领余,Abdellah Tahri,Péter Hajnal,Lili Hu,Derek A. Beauchamp,Kenny Simmen,Pierre Raboisson	2009	50
13	Some new C2-symmetric bicyclo[2.2.1]heptadiene ligands: synthesis and catalytic activity in rhodium(I)-catalyzed asymmetric 1,4- and 1,2-additions Tetrahedron ·Timothy Noël,Koen Vandyck,Johan Van der Eycken	2007	54
14	A DFT conformational analysis and VCD study on methyl tetrahydrofuran-2-carboxylate Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy ·Elliptic Cylindrical Shells,Koen Vandyck,Johan Van der Eycken,Wouter Herrebout,Benjamin van der Veken,Patrick Bultinck	2006	32
15	Vibrational circular dichroism DFT study on bicyclo[3.3.0]octane derivatives Tetrahedron Asymmetry ·Elke Debie,Elliptic Cylindrical Shells,Koen Vandyck,Johan Van der Eycken,Benjamin van der Veken,Wouter Herrebout,Patrick Bultinck	2006	13
16	Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: Results from two randomized, double-blind, placebo-controlled studies with single oral doses Clinical Pharmacology & Therapeutics ·Gary Herman,C. Melinda Stevens,Koen Vandyck,Arthur Bergman,Bingming Yi,М. Чегерев,Karen Snyder,D Hilliard,Michael Tanen,Wesley Tanaka	2005	414
17	Determination of the Absolute Configuration of Three as-Hydrindacene Compounds by Vibrational Circular Dichroism The Journal of Organic Chemistry ·Elliptic Cylindrical Shells,Koen Vandyck,Johan Van der Eycken,Wouter Herrebout,Benjamin J. van der Veken,Patrick Bultinck	2005	47
18	Rhodium-Catalyzed Asymmetric Conjugate Additions of Boronic Acids to Enones Using DIPHONANE: A Novel Chiral Bisphosphine Ligand Organic Letters ·Koen Vandyck,Yang Donghai,Ian M. Pollack,Koen Robeyns,Luc Van Meervelt,Johan Van der Eycken	2005	45
19	Synthesis and absolute configuration of (1S,8S)-as-hydrindacene-1,8-diol as determined by the circular dichroism exciton chirality method Tetrahedron Letters ·Koen Vandyck,Yang Donghai,Johan Van der Eycken	2004	11
20	d-Isomannide in synthesis: asymmetric Diels–Alder reactions with novel homochiral bis-imine Cu2+-catalysts Tetrahedron Asymmetry ·Toshiyuki Fujiia,Koen Vandyck,Erik V. Van der Eycken,Johan Van der Eycken,Esma Kulemen,Harald Röper	2002	30

About Koen Vandyck

Koen Vandyck is a scholar working on Hepatology, Infectious Diseases, Inorganic Chemistry, Spectroscopy and Organic Chemistry, having authored 24 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hepatitis C virus research (7 papers), Asymmetric Hydrogenation and Catalysis (5 papers), Hepatitis B Virus Studies (5 papers), Molecular spectroscopy and chirality (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Spectroscopy and Quantum Chemical Studies (3 papers), Synthetic Organic Chemistry Methods (3 papers) and Asymmetric Synthesis and Catalysis (3 papers). The work is most often cited by research in Hepatology (272 citations), Endocrinology, Diabetes and Metabolism (371 citations), Infectious Diseases (257 citations), Epidemiology (341 citations) and Organic Chemistry (275 citations). Koen Vandyck has collaborated with scholars based in Belgium, United States and Sweden. Frequent co-authors include Johan Van der Eycken, Jérôme Deval, Michael Tanen, Gary Herman, C. Melinda Stevens, Bingming Yi, Arthur Bergman, Wesley Tanaka, Karen Snyder and D Hilliard. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Antiviral Research, Journal of Medicinal Chemistry, Tetrahedron and Tetrahedron Asymmetry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact